When a cancer drug is labeled “FDA approved,” most people assume it means longer life and real benefit. But that assumption is often wrong.
In this episode, Dr. David Quartell breaks down a hard but critical truth: over the past few decades, less than half of FDA-approved cancer drugs have ever been shown to extend life—yet many cost tens of thousands of dollars per month and remain widely prescribed.
We explore how approval standards changed, what “progression-free survival” really means, why profit incentives shape treatment decisions, and how patients often pay the price in time, side effects, and false hope. Most importantly, we discuss what real innovation should look like—and why prevention, lifestyle medicine, and evidence-based support are still being sidelined.
This isn’t anti-science. It’s pro-truth. And it’s a conversation every patient and family deserves to hear.